Bone Biologics (BBLG) Competitors $2.23 -0.12 (-5.11%) Closing price 03:55 PM EasternExtended Trading$2.22 0.00 (-0.22%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. STSS, QNRX, NDRA, CHEK, VERO, TIVC, AEMD, GCTK, XAGE, and BLACShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Sharps Technology (STSS), Quoin Pharmaceuticals (QNRX), ENDRA Life Sciences (NDRA), Check-Cap (CHEK), Venus Concept (VERO), Tivic Health Systems (TIVC), Aethlon Medical (AEMD), GlucoTrack (GCTK), Longevity Health (XAGE), and Bellevue Life Sciences Acquisition (BLAC). These companies are all part of the "medical equipment" industry. Bone Biologics vs. Its Competitors Sharps Technology Quoin Pharmaceuticals ENDRA Life Sciences Check-Cap Venus Concept Tivic Health Systems Aethlon Medical GlucoTrack Longevity Health Bellevue Life Sciences Acquisition Sharps Technology (NASDAQ:STSS) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Which has more volatility & risk, STSS or BBLG? Sharps Technology has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Comparatively, Bone Biologics has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Is STSS or BBLG more profitable? Sharps Technology's return on equity of -11.64% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Sharps TechnologyN/A -11.64% -5.79% Bone Biologics N/A -130.21%-119.39% Do insiders and institutionals have more ownership in STSS or BBLG? 17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 0.2% of Sharps Technology shares are held by company insiders. Comparatively, 6.1% of Bone Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media refer more to STSS or BBLG? In the previous week, Sharps Technology and Sharps Technology both had 3 articles in the media. Sharps Technology's average media sentiment score of 1.96 beat Bone Biologics' score of -0.04 indicating that Sharps Technology is being referred to more favorably in the media. Company Overall Sentiment Sharps Technology Very Positive Bone Biologics Neutral Which has preferable earnings and valuation, STSS or BBLG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSharps TechnologyN/AN/A-$9.30M-$1.21 thousand0.00Bone BiologicsN/AN/A-$4.11MN/AN/A SummarySharps Technology beats Bone Biologics on 4 of the 7 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$3.13B$5.68B$9.81BDividend YieldN/A2.23%4.61%4.07%P/E RatioN/A20.7730.6825.56Price / SalesN/A370.75464.10116.64Price / CashN/A43.0338.2159.48Price / Book0.278.608.996.13Net Income-$4.11M-$54.65M$3.25B$264.89M7 Day Performance-4.29%6.55%4.78%2.67%1 Month Performance-23.10%9.54%6.80%3.11%1 Year Performance-74.72%14.08%30.61%25.14% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics1.676 of 5 stars$2.23-5.1%N/A-71.6%$1.23MN/A0.002Earnings ReportShort Interest ↓STSSSharps Technology2.0567 of 5 stars$4.68+1.5%N/AN/A$4.72MN/A0.003Earnings ReportShort Interest ↓Gap DownQNRXQuoin Pharmaceuticals1.0445 of 5 stars$7.25+8.2%N/A-56.3%$3.94MN/A-0.154Gap UpNDRAENDRA Life Sciences3.1616 of 5 stars$5.13+0.6%$50.00+874.7%-99.9%$3.84MN/A-0.0320News CoverageNegative NewsEarnings ReportShort Interest ↓CHEKCheck-Cap0.4219 of 5 stars$0.63-3.7%N/A-63.8%$3.81MN/A0.0080Short Interest ↑High Trading VolumeVEROVenus Concept1.4847 of 5 stars$2.49+0.4%N/A-63.2%$3.53M$64.83M0.00410News CoverageEarnings ReportTIVCTivic Health Systems0.512 of 5 stars$3.38+5.3%N/A-34.0%$3.34M$780K0.0010News CoverageEarnings ReportShort Interest ↑Gap UpTrading HaltedAEMDAethlon Medical2.3906 of 5 stars$1.20-0.8%$56.00+4,566.7%-62.0%$3.13M$570K-0.0910News CoverageEarnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionGCTKGlucoTrack0.2068 of 5 stars$5.83-3.2%N/A-99.7%$2.87MN/A0.005News CoverageEarnings ReportXAGELongevity HealthN/A$2.80-1.4%N/AN/A$2.85M$50K0.0014Earnings ReportBLACBellevue Life Sciences AcquisitionN/A$0.66+2.0%N/A-94.9%$2.65MN/A0.00N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies STSS Alternatives QNRX Alternatives NDRA Alternatives CHEK Alternatives VERO Alternatives TIVC Alternatives AEMD Alternatives GCTK Alternatives XAGE Alternatives BLAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access